top of page

NCI-2019-08392

A PHASE 1 STUDY OF ZN-c3 AS A SINGLE AGENT IN SUBJECTS WITH SOLID TUMORS


This study is testing a new medicine called ZN-c3 to see if it's safe for people with solid tumors. They want to see how well the medicine works on its own and if it can help treat cancer.


For more information about the trial, click the link below:

Clinical Trial Site: Sinai


To see all available clinical trials click here.



 
 
 

Recent Posts

See All
NCI-2025-06021

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer (TRIPL) This is a research study exploring how combining radiation therapy with dual immune check

 
 
 
NCI-2024-05588

A Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT) The INSI

 
 
 
NCI-2022-08569

Randomized Phase III Trial of mFOLFIRINOX /- Nivolumab vs. FOLFOX /- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma This randomized Phase III research

 
 
 

Comments

bottom of page